1.0The Medical Xchangehttps://themedicalxchange.com/en/New Approach Improves Symptoms and Functioning in ADHD - The Medical Xchangerich600338<blockquote class="wp-embedded-content" data-secret="8VsPL8p3xy"><a href="https://themedicalxchange.com/en/2011/10/18/aacapcacap-joint-annual-meeting-2/">New Approach Improves Symptoms and Functioning in ADHD</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://themedicalxchange.com/en/2011/10/18/aacapcacap-joint-annual-meeting-2/embed/#?secret=8VsPL8p3xy" width="600" height="338" title="“New Approach Improves Symptoms and Functioning in ADHD” — The Medical Xchange" data-secret="8VsPL8p3xy" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://themedicalxchange.com/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
https://themedicalxchange.com/wp-content/uploads/2011/10/AACAP_Figure_1.PNG960720Toronto – A long-acting stimulant is the usual first-line therapy for most patients with attention deficit hyperactivity disorder (ADHD). Still, a substantial minority of individuals – as many as one in three – do not have an adequate response to these agents. In addition, some patients or their parents may prefer or require other therapeutic options. Data presented at this meeting provided insight on the efficacy of new approaches – employing the alpha-2 agonist guanfacine as monotherapy or in addition to a stimulant – in decreasing ADHD symptom scores and improve functioning.